Anti-osteoporotic medication and scleroderma
Scleroderma (systemic sclerosis) represents a challenging condition, usually requiring a multi-disciplinary team due to multi-organ involvement; it is mostly considered an autoimmune disease; the signature of the malady is the extensive fibrosis at the level of skin and multiple organs, associating...
Main Authors: | Florica Sandru, Mihai Cristian Dumitrascu, Diana Elena Rentea, Stefania Zugravu, Aida Petca, Claudia Mehedintu, Mara Carsote |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2021-12-01
|
Series: | Romanian Journal of Medical Practice |
Subjects: | |
Online Access: | https://rjmp.com.ro/articles/2021.4/RJMP_2021_4_Art-10.pdf |
Similar Items
-
Endocrine issues and premenopausal breast cancer
by: Mara Carsote, et al.
Published: (2021-12-01) -
Follow-up of second adrenal tumor after remission of Cushing syndrome
by: Mihai Cristian Dumitrascu, et al.
Published: (2021-12-01) -
A Study of Bone Density of Scleroderma Patients and Comparison with Control Group in Khuzestan Province since in the Last Three Years
by: B Hadian, et al.
Published: (2004-07-01) -
Monogenetic osteoporosis: Does the risk of fall matter?
by: Mihai Cristian Dumitrascu, et al.
Published: (2021-09-01) -
COVID-19 era and thyroid surgery
by: Florica Sandru, et al.
Published: (2021-12-01)